Page 19 - Platform Technology News Today

Cingulate Announces Successful Transfer of CTx-1301 Proprietary PTR™ Manufacturing Processes to Societal CDMO Scalable Supply of CTx-1301 Ready to be... | May 3, 2023

Swiss biotech Gnubiotics Sciences SA, a pioneering company in glyco-immunology research to develop human therapeutics, is pleased to announce the appointment of two highly respected individuals as senior

Managements Discussion and Analysis of Financial Condition and Results of Operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with... | May 3, 2023

/PRNewswire/ -- Proflexa is a groundbreaking solution to daily aches and pains. The formula was developed by the creative minds at the innovative health brand...

/PRNewswire/ -- The founders of the scientifically-driven natural health brand Sinoveda understand that the natural supplement industry is hardly known for its...

03.04.2023 - Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 ...

Team Phagel from UCL London wins first prize at SCI's 2023 Bright SCIdea finalWinning business idea could address 50% figure of burn victims who die from infectionLONDON, March 31, 2023 /PRNewswire/

/PRNewswire/ -- Calcium is an important nutritional need of every human. However, most calcium supplements lead to unwelcome side effects. Mayo Clinic...

/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...

Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in Multibillion-Dollar